Learn more

ASAT AG APPLIED SCIENCE & TECH

Overview
  • Total Patents
    65
About

ASAT AG APPLIED SCIENCE & TECH has a total of 65 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are INST ADVANCED SKIN RES INC, SKINVISIBLE PHARMACEUTICALS IN and MANN MORRIS A.

Patent filings per year

Chart showing ASAT AG APPLIED SCIENCE & TECHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Schmid Hans W 40
#2 Berchtold Peter 8
#3 Burmeister Gerd 7
#4 Escher Robert F A 7
#5 Elsner Peter 5
#6 Hans W Schmid 3
#7 Escher Robert 2
#8 Gerd Burmeister 1
#9 Berchtold Peter Dr Med 1
#10 Bunke Antje 1

Latest patents

Publication Filing date Title
AU2003278164A1 Daily melatonin dosing units
CN101897736A Formulations containing melatonin, ginkgo biloba, and biotin
DE10250646A1 Cosmetic and/or pharmaceutical hair treatment compositions, especially for promoting hair growth, containing melatonin (or derivative) and Gingko biloba and biotin as potentiating agents
US2004043390A1 Use of nucleotide sequences as carrier of cultural information
DE10110418A1 Melatonin Vitamin A supplements
DE10057443A1 Use of specific antibodies, or individual chains, for treating tumors and vascular occlusions, by inhibition of the gpIIb/IIIa receptor
DE10003620A1 Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy
DE19957710A1 Treating female type androgenetic or diffuse alopecia by topical administration of melatonin, causing e.g. reduction of telogen rate and increase of anagen rate, hair diameter and tensile strength
DE19852245A1 5-aminolevulinic acid nanoemulsion
AU8436798A Anti-GPIIb/IIIa recombinant antibodies
DE19820663A1 Recombinant antibodies